Melissa B. Epperly, Chief Financial Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 4,461 shares at $51.15 ($229K) on 2021-07-01, disclosed to the SEC on 2021-07-06.
Open-market sale of $229k ZNTL by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.10 | 700 | $35K | 15.3% |
| 2 | $51.15 | 1,378 | $70K | 30.8% |
| 3 | $51.15 | 1,378 | $70K | 30.8% |
| 4 | $52.01 | 805 | $42K | 18.3% |
| 5 | $53.19 | 200 | $11K | 4.7% |
| Total | $51.23 avg | 4,461 |
| $229K |
| 100% |
| Filing → |
| ROIV | SELL | 2026-07-01 | $610K | — | Filing → |
| ROIV | SELL | 2026-03-18 | $1.2M | — | Filing → |
| ZNTL | SELL | 2024-02-12 | $29K | — | Filing → |